Zhongwei Zhao

Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study

Liyun Zheng, Shiji Fang, Fazong Wu et al. · Frontiers in Molecular Biosciences · 2021 · 87 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Tumor cell-intrinsic MELK enhanced CCL2-dependent immunosuppression to exacerbate hepatocarcinogenesis and confer resistance of HCC to radiotherapy

Bufu Tang, Jinyu Zhu, Yueli Shi et al. · Molecular Cancer · 2024 · 41 citations · Full text

Medicine, Cancer Biology, Oncology +14

Long Non-Coding RNA PCAT6 Induces M2 Polarization of Macrophages in Cholangiocarcinoma via Modulating miR-326 and RhoA-ROCK Signaling Pathway

Jianfei Tu, Fazong Wu, Li Chen et al. · Frontiers in Oncology · 2021 · 40 citations · Full text

Life Sciences, Immunology, Oncology +17

Potentiated Calcium Carbonate with Enhanced Calcium Overload Induction and Acid Neutralization Capabilities to Boost Chemoimmunotherapy against Liver Cancer

Liyun Zheng, Yiming Ding, Shiji Fang et al. · ACS Nano · 2024 · 39 citations

Pharmacy, Oncology, Pharmacology +17

miR‐199a‐3p and miR‐214‐3p improve the overall survival prediction of muscle‐invasive bladder cancer patients after radical cystectomy

Thorsten Ecke, Katja Stier, Sabine Weickmann et al. · Cancer Medicine · 2017 · 34 citations · Full text

Medicine, Oncology, Urology +17